Stocks · News reference
CORRECTION: Addex Therapeutics Q2 EPADS $(2.16) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.16) per share. This is a 25.52 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Addex Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript
Addex Therapeutics (NASDAQ:ADXN) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
Earnings Scheduled For September 28, 2026
Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnings for its first quarter. • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $0.20 per share on revenue